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ing and Data System (BI-RADS) [1] is a useful operating
manual established by a group of multidisciplinary experts.
The main contents include the terms describing the char-
acteristics of lesions and the organizational reporting
structure (classification of test results and follow-up man-
agement measures as well as medical evaluation). With this
system, we can establish a standardized report in terms of
both content and format, which improves communication
between physicians and measures the effectiveness of
image interpretation at the individual and medical institu-
tion level. Therefore the true value of BI-RADS is: improving
the quality of patient care through management and stan-
dardization of scanning technologies; producing reliable
reports; and enabling the monitoring of health care
effectiveness.
The 2013 edition once again emphasizes that image
quality is a prerequisite to accurate diagnosis. It recom-
mends the use of a broadband transducer with a central
frequency with at least 10 MHz and a high frequency
ranging from 12 MHz to 18 MHz in order to ensureConflicts of interest: The author declares no conflicts of
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must be familiar with breast anatomy and the corre-
sponding ultrasound features. Before scanning, the gray-
scale gain should be adjusted to make the subcutaneous
adipose tissue a shade of moderate gray, never
black. Measurement of the lesions must include: the
longest diameter (), the length (B) perpendicular to the
longest diameter (), and the length (,) scanned
perpendicular to the preceding original image, as shown in
Fig. 1.
In terms of the structure of breast imaging reporting, a
summary of the report is as follows:
(1) State whether the indication under inspection is a
screening or a diagnosis.
(2) Explain the range and technology of ultrasound im-
aging. For example, is a specific site being examined,
or is this an added screening for testing breast den-
sity? Is the test conducted by a technician or a
physician, or by an automatic scanner?
(3) Describe the breast composition (for screening). This
feature is mainly divided into: (a) a homogenous
background with fibroglandular tissue; (b) a homog-
enous background with fatty tissue; and (c) a het-
erogeneous background with a mixture of low- and
high-echo areas.
(4) Give important findings. We recommend the use of
standard terms for describing breast lumps, breast
calcifications, changes in the surrounding tissues, andf Ultrasound in Medicine. Open access under CC BY-NC-ND license.
Fig. 1 Optimal orientation of imaging.
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positive rate of breast ultrasound, reducing the
number of the unnecessary biopsies is important, and
breast elastography has been added to the new edi-
tion for assessing the elasticity of breast lumps.
However, it should be noted that, although various
aspects need to be considered when describing the
lesions, the most worrisome characteristic should stillTable 1 The standard terms proposed for breast ultrasound.be the major concern for classification and
management.
(5) Give a comparison with prior images and other image
results (e.g., mammography and magnetic resonance
angiography) if available. For calcifications,
mammography is more sensitive and accurate than
breast ultrasound. In addition, the small noncalcified
lesions identified by mammography usually cannot be
easily found by using breast ultrasound alone.
Therefore, comparison with other imaging tests is a
significant factor in improving the accuracy of breast
ultrasound.
(6) Provide an integrated report of tests conducted on
the same day. If several breast examinations are
performed on the same day, the contents of the
report need to be separated, with the different ex-
aminations in different paragraphs. The test result
Table 2 Diagnosis results of mammography (breast ultrasound) and recommended management measures according to the
Breast Imaging Reporting and Data System.
Assessment Management Likelihood of cancer
Category 0: Incompletedneed additional
imaging evaluation
Recall for additional imaging N/A
Category 1: Negative Routine screening Essentially 0% likelihood of
malignancy
Category 2: Benign Routine screening Essentially 0% likelihood of
malignancy
Category 3: Probably benign Short-interval (6-month) follow-up or
continued surveillance
>0% but  2% likelihood of
malignancy
Category 4: Suspicious Tissue diagnosis >2% but < 95% likelihood of
malignancy
Category 4A: Low suspicion for malignancy >2% to  10% likelihood of
malignancy
Category 4B: Moderate suspicion for
malignancy
>10% to  50% likelihood of
malignancy
Category 4C: High suspicion for malignancy >50% to < 95% likelihood of
malignancy
Category 5: Highly suggestive of malignancy Tissue diagnosis 95% likelihood of malignancy
Category 6: Known biopsy-proven malignancy Surgical excision when clinically appropriate N/A
ACR BI-RADS Ultrasound 119with the highest concern should be used as the basis
for determining the measures for case management.
(7) Provide assessment categories (Table 2). Most breast
ultrasound scans are diagnostic tests and comparison
with prior images or other images is usually not
possible immediately. Thus, Category 0 can be
assigned temporarily and a final classification can be
determined once image comparison is finished. It
should be noted that, when assigning Category 3, the
likelihood of the lesion being malignant is very low
(2%) and the expected possibility of change within
the short-term follow-up is not high; the lesion is still
an early-stage cancer even if it changes. The follow-
up method is: (a) schedule the first follow-up 6
months (Month 6) after the initial diagnosis and the
second follow-up at a 6-month interval (Month 12) if
no change in the first follow-up; (b) schedule the
third follow-up at a 12-month interval (Month 24) if
no change in the second follow-up; and (c) schedule
the fourth follow-up at a 12-month interval (Month
36) if no change in the third follow-up. The follow-upperiod is usually 2e3 years and can be considered as
Category 2.
(8) Recommended management measures (see Table 2).
BI-RADS must be determined from the evidence-based
medicine or consensus of the experts. Nonetheless, this
does not mean it can never be changed. It will change along
with new technology or modifications of the methods of
clinical tests. For breast imaging, BI-RADS is the most
widely used guideline worldwide and we encourage its use
because it is an important reference for implementing self-
assessment, publishing research results, and enhancing
health care quality, in addition to connecting us to the
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